RVPH - Latest News
Reviva Pharmaceuticals Holdings, Inc. (RVPH), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.2M. Beta to the broader market is 0.75.
The article list below shows the most recent RVPH headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RVPH Headlines
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com - May 13, 2026
- Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Consensus Rating of “Moderate Buy” from Analysts
defenseworld.net - Apr 6, 2026
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight brokerage
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
globenewswire.com - Mar 30, 2026
- Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine
What's Behind The Drop In Reviva Pharmaceuticals Stock?
benzinga.com - Mar 19, 2026
According to an SEC filing from Wednesday, Reviva will sell 6,666,667 common shares priced at $1. 50 each, a move that will raise more than $10 millio
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
globenewswire.com - Mar 18, 2026
CUPERTINO, Calif. , March 18, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc.
How News Affects RVPH Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RVPH's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked RVPH news questions
- What is the latest RVPH news headline?
- The most recent RVPH headline (May 13, 2026) is "Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RVPH news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RVPH news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RVPH options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.